Medtronic Resolute Onyx 2.0 mm Clinical Study

NACompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

April 6, 2015

Primary Completion Date

February 13, 2017

Study Completion Date

February 21, 2019

Conditions
Coronary Artery Disease
Interventions
DEVICE

Resolute Onyx Stent - 2.0 mm

Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent

Trial Locations (17)

10016

NYU Langone Medical Center, New York

10029

The Mount Sinai Medical Center, New York

11576

Saint Francis Hospital, Roslyn

17822

Geisinger Medical Center, Danville

19096

Lankenau Medical Center, Wynnewood

27705

Duke University Medical Center, Durham

29621

AnMed Health Medical Center, Anderson

33756

Morton Plant Hospital, Clearwater

37205

Centennial Medical Center, Nashville

44035

University Hospitals Elyria Medical Center, Elyria

46290

St. Vincent Heart Center of Indiana, Indianapolis

58102

Sanford Medical Center, Fargo

62701

Saint John's Hospital, Springfield

63110

Barnes Jewish University, St Louis

75216

Dallas VA Medical Center, Dallas

75701

East Texas Medical Center, Tyler

92037

Scripps Green Hospital, La Jolla

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medtronic Vascular

INDUSTRY